J. Mel Sorensen
President, Chief Executive Officer and Chair of the Board
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2012-01-01–2026-08-03
-
Start not stated–2026-08-03
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $619,479 | $747,821 |
| 2024 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $619,479 | $633,279 |
| 2022 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $596,860 | $1,361,448 |
| 2021 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $568,438 | $2,534,676 |
| 2020 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $545,700 | $2,958,232 |
| 2019 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $431,602 | $2,465,102 |
| 2018 | Galera Therapeutics, Inc. (GRTXD) | M.D., President and Chief Executive Officer | $386,388 | $521,624 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.